These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 22761409

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
    Racil Z, Winterova J, Kouba M, Zak P, Malaskova L, Buresova L, Toskova M, Lengerova M, Kocmanova I, Weinbergerova B, Timilsina S, Rolencova M, Cetkovsky P, Mayer J.
    Mycoses; 2012 Nov; 55(6):483-92. PubMed ID: 22429709
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O.
    Clin Infect Dis; 2008 Jan 15; 46(2):201-11. PubMed ID: 18171251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
    Seyedmousavi S, Mouton JW, Verweij PE, Brüggemann RJ.
    Expert Rev Anti Infect Ther; 2013 Sep 15; 11(9):931-41. PubMed ID: 24053274
    [Abstract] [Full Text] [Related]

  • 9. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR.
    Pediatr Infect Dis J; 2002 Mar 15; 21(3):240-8. PubMed ID: 12005089
    [Abstract] [Full Text] [Related]

  • 10. Voriconazole therapeutic drug monitoring: focus on safety.
    Pasqualotto AC, Xavier MO, Andreolla HF, Linden R.
    Expert Opin Drug Saf; 2010 Jan 15; 9(1):125-37. PubMed ID: 20021293
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
    Chu HY, Jain R, Xie H, Pottinger P, Fredricks DN.
    BMC Infect Dis; 2013 Feb 26; 13():105. PubMed ID: 23442261
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H, Dupont B, Lode H, Denning DW.
    Am J Med; 2006 Jun 26; 119(6):527.e17-24. PubMed ID: 16750972
    [Abstract] [Full Text] [Related]

  • 17. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A, Hoffman J, Sheth A.
    Ann Pharmacother; 2008 Dec 26; 42(12):1859-64. PubMed ID: 19017830
    [Abstract] [Full Text] [Related]

  • 18. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA.
    J Infect; 2007 Nov 26; 55(5):445-9. PubMed ID: 17822770
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Shang W, Feng G, Sun R, Wang X, Liu W, Zhang S, Li J, Pang X, Wang Y, Zhang W.
    J Clin Pharm Ther; 2012 Dec 26; 37(6):652-6. PubMed ID: 22725946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.